by Clinton Bowman
The numbers continue to grow as more COVID-19 cases have been reported in Yoakum County.
As of press time on Tuesday 145 cases have been recorded in Yoakum County with 116 recovered. The total number for the South Plains is setting at 11,454 up from the 10,174 recorded just one week ago. Lubbock County continues to lead the way with 7,485 cases, 5,635 recovered, and 100 deaths.
The United States has reported 6,031,582 cases with 1,918,780 recovered. The death total as of Tuesday, August 31 stands at 183,602, but that number continues to grow each day.
Texas is now the third leading state in recorded cases with 632,818 cases and 9,952 recoveries. California leads all states with 634,388 cases and 11,349 recoveries. Florida follows with 576,095 cases and 9,539 recoveries.
Many discrepancies have been noted in these large numbers with reports of cases and/or deaths being counted two times or even more.
Other South Plains counties include Hale county with 1,618 cases and 1,497 recovered, Hockley County has recorded 257 cases and 208 recovered, Gaines county has 247 cases and 194 recovered, and Terry County has 203 cases and 175 recovered.
With school recently starting back each child and teacher were required to wear a face mask as mandated by Governor Greg Abbott. It has been learned that an individual in a DCISD facility was identified as having tested positive for COVID-19 on Monday, August 17. As a result of the health and safety measures in place, no individuals were identified as being in close contact with the infected person.
Everyone is asked to continue to wear a mask, keep your social distancing, and continue practicing safety measures to prevent the spread of COVID-19.
As of Monday, there were 8,474 confirmed cases of COVID-19 on the South Plains with Lubbock county leading the way with 5,654 cases. Hale county has reported 1,185 cases, Bailey County has reported 197 cases, Hockley County has reported 174, and Scurry county has reported 201. Unfortunately, those numbers continue to grow each day.
In a news release an experimental vaccine being developed by AstraZeneca and Oxford University against the new coronavirus produced an immune response in early-stage clinical trials, data showed on Monday, preserving hopes it could be in use by the end of the year.
The vaccine, called AZD1222, has been described by the World Health Organization’s chief scientist as the leading candidate in a global race to halt a pandemic that has killed more than 600,000 people.